高容量脂肪移植联合或不联合Goldilocks乳房切除术的乳房再造临床结局
回顾性分析25例患者39侧乳房再造,比较单纯脂肪移植(19例28侧)与Goldilocks联合脂肪移植(6例11侧)的重建时间线与结局。单纯脂肪移植组平均4次移植,联合组2.64次(P=0.03);单侧平均注射总量分别为664 mL与495 mL(P=0.111),无显著差异。脂肪移植相关并发症4例(10%),Goldilocks术后血清肿3例(27%),无肿瘤复发。作者认为高容量脂肪移植是成功且安全的乳房再造方式,联合Goldilocks时可减少手术次数。
要点
- 单纯脂肪移植组平均需4次移植,联合Goldilocks组平均2.64次,差异有统计学意义(P=0.03)。
- 单侧平均注射脂肪总量单纯组664 mL,联合组495 mL,两组无显著差异(P=0.111)。
- 脂肪移植相关并发症4例(10%),Goldilocks术后血清肿3例(27%),无肿瘤复发。
核心结论
- 高容量脂肪移植是成功且安全的乳房再造方式,尤其联合Goldilocks乳房切除术时可用较少手术次数获得良好体积。
- 本研究描绘了该自体、安全再造选项可靠的时间线。
研究设计与样本
- 回顾性综述,单术者经验,患者接受单纯脂肪移植或联合Goldilocks乳房切除术的全自体乳房再造。
- 共纳入25例患者39侧乳房再造;单纯脂肪移植组19例28侧,Goldilocks联合脂肪移植组6例11侧。
主要发现
- 单纯脂肪移植组平均移植4次,Goldilocks联合组平均2.64次,差异有统计学意义(P=0.03)。
- 单纯脂肪移植组单侧平均注射脂肪总量664 mL,Goldilocks联合组495 mL,两组无显著差异(P=0.111)。
- 单纯脂肪移植组前5次移植每次注射量相近,第5次之后移植量显著下降(P<0.001)。
- 报告4例脂肪移植相关并发症(10%),3例患者Goldilocks乳房切除术后出现血清肿(27%)。
- 无肿瘤复发。
关键数值与推荐
- 单纯脂肪移植组平均移植次数4次,Goldilocks联合组2.64次(P=0.03)。
- 单纯脂肪移植组单侧平均注射脂肪总量664 mL,Goldilocks联合组495 mL(P=0.111)。
- 单纯脂肪移植组前5次移植注射量相近,第5次后移植量显著下降(P<0.001)。
- 脂肪移植相关并发症4例(10%),Goldilocks术后血清肿3例(27%),无肿瘤复发。
临床怎么用
- 作者认为高容量脂肪移植是成功且安全的乳房再造形式。
- 作者指出联合Goldilocks乳房切除术时可用较少手术次数获得良好体积,并描绘了该再造选项可靠的时间线。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
High-volume fat grafting is an autologous reconstructive technique that provides women with a minimally invasive surgical option, yet there remains a paucity of literature examining details about the reconstructive timeline and outcomes of this procedure. This study presents a retrospective review of a single surgeon's experience performing total autologous breast reconstruction using fat grafting alone or in combination with Goldilocks mastectomies. Our population included 39 breast reconstructions in 25 patients. Nineteen patients (28 breasts) had fat grafting only and 6 patients (11 breasts) had Goldilocks and fat grafting. On comparison, the fat grafting only group averaged 4 grafting sessions while the Goldilocks combined group averaged 2.64 sessions (P = 0.03). In the fat grafting only group, the total average volume of fat injected into each breast was 664 mL, and it was not significantly different from the Goldilocks combined group with 495 mL of fat (P = 0.111). In the fat grafting only group, there was a similar amount of fat injected in the first 5 grafting sessions; following the 5th session, there was a significant drop in volume grafted (P < 0.001). Four fat grafting-related complications were reported (10%) and 3 patients developed seromas following their Goldilocks mastectomies (27%). There were no tumor recurrences. We can conclude from this data that high-volume fat grafting is a successful and safe form of breast reconstruction. We show good volume achieved with minimal procedures necessary, especially when combined with Goldilocks mastectomies. This study depicts a reliable timeline for this autologous and safe reconstructive option.
引用
- Sarrami SM, Humar P, Marallo MJ, et al. High-Volume Fat Grafting With and Without Goldilocks Mastectomies Show Successful Clinical Outcomes for Breast Reconstruction. Ann Plast Surg. 2025. PMID: 40167077. doi:10.1097/SAP.0000000000004212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。